{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-210079","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.908674+00:00","generated_at":"2026-06-24T05:51:56.489690+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Apellis exchanges $22.5M convertible notes for shares; prior $75.6M exchange closed Aug 1","bullets":["Signed exchange agreements on July 28 to convert $22.5M in 3.5% convertible notes due 2026 into common stock.","Consideration includes 456,128 shares fixed plus additional shares based on volume-weighted average price over 3 trading days.","Prior exchange of $75.6M principal closed Aug 1, issuing 2,334,014 shares—combined ~$98.1M of notes converted.","Shares issued in private placement to QIBs and accredited investors; no registration under Securities Act.","No cash interest paid on exchanged notes; holders waived accrued interest and conversion rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-210079","json":"https://secwatch.observer/filing/0001193125-22-210079.json","markdown":"https://secwatch.observer/filing/0001193125-22-210079.md","text":"https://secwatch.observer/filing/0001193125-22-210079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312522210079/0001193125-22-210079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312522210079/d385179d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:51:56.489690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}